Patent details

EP1272193 Title: SYNERGISTIC COMBINATION THERAPY FOR TREATING CANCER

Basic Information

Publication number:
EP1272193
PCT Application Number:
PCT/US/2001/009193
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019206531
PCT Publication Number:
WO/2001/072721
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SYNERGISTIC COMBINATION THERAPY FOR TREATING CANCER
French Title of Invention:
THÉRAPIE PAR DES COMBINAISONS SYNERGÉTIQUES POUR LE TRAITEMENT DU CANCER
German Title of Invention:
SYNERGISTISCHE KOMBINATIONSTHERAPIE ZUR KREBSBEHANDLUNG
SPC Number:

Dates

Filing date:
22/03/2001
Grant date:
06/05/2009
EP Publication Date:
06/05/2009
PCT Publication Date:
04/10/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/01/2003
EP B1 Publication Date:
06/05/2009
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/03/2010
Expiration date:
22/03/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/03/2001
 
 

Name:
Bristol-Myers Squibb Company
Address:
Lawrenceville-Princeton Road P.O. Box 4000, Princeton NJ 08543-4000, United States (US)

Inventor

Name:
LEE Francis, Y.
Address:
United States (US)

Priority

Priority Number:
192278 P
Priority Date:
27/03/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/5513;
Filing date Document type Number of pages